Portfolio company
Bioinvent International
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops antibody-based immunotherapies for cancer patients and provides contract manufacturing services to pharmaceutical firms and academic institutions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Bioinvent
This clinical-stage biotechnology company develops antibody-based therapies for cancer treatment for pharmaceutical partners and produces drug substances for clinical trials.
imbiologics
The company develops antibody therapeutics for autoimmune diseases and cancer, providing these biological medicines to pharmaceutical firms and healthcare providers.
Eubiologics
This biopharmaceutical company manufactures vaccines for global health organisations and provides contract research and manufacturing services to the biotechnology industry.
trioar
This biotechnology firm develops antibody-based therapeutic platforms and drug conjugates for pharmaceutical companies and research partners to treat cancer.
Innate Pharma
This biotechnology company develops antibody-based immunotherapies for cancer and inflammatory diseases for patients with unmet medical needs.
53Biologics
This company provides contract development and manufacturing services for recombinant proteins and plasmid DNA to biotechnology and pharmaceutical firms.
Exomnis Biotech
This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.
Abzena
This company provides discovery, development and manufacturing services for biologics and bioconjugates to biotechnology and pharmaceutical customers.
